Synact Pharma News and Activities

Synact Pharma is a company listed under the stock ticker SYNACT (STO).

View the org chart displaying its 11 main executives

Most searched biographies at Synact Pharma

• Jeppe Ovlesen, Chief Executive Officer and Director
• Sten Sörensen, Director
• Anders Kronborg, Chairman of the Board

Popular executive movements at Synact Pharma

• Ann Kristin will join the company as Chief Financial Officer on Mar. 1, 2026  (posted on February 25 2026).
• Malin Wikstrand, who was Financial Controller, is promoted to Interim Chief Financial Officer  (posted on January 19 2026).
• Björn Westberg, Chief Financial Officer, has left the company  (posted on January 19 2026).

Create your alert
to follow the executive moves at Synact Pharma.

Synact Pharma has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Catalyst Pharmaceuticals, listed under ticker CPRX, has been delisted. (posted on July 13 2026).
• Angelini Pharma has acquired Catalyst Pharmaceuticals (posted on July 13 2026).
• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Synact Pharma

• News and Press Releases - SynAct Pharma
• Press Releases - SynAct Pharma
• Press Releases - SynAct Pharma
• Press Releases - SynAct Pharma
• Synact Pharma to present at the ABGSC Life Science Summit - SynAct Pharma

Social media about Synact Pharma

• Synact Pharma on Wikipedia, Google News & Yahoo Finance
• Synact Pharma on LinkedIn, X (Twitter) & YouTube